- Description
-
Details
This continuing education course explores the critical role of fatty acid metabolism in the brain and its association with the pathophysiology of Alzheimer disease and cognitive decline. Altered lipid metabolism has been increasingly recognized as a key contributor to neurodegeneration, influencing processes such as amyloid-β accumulation, tau pathology, neuroinflammation, and synaptic integrity. Understanding these mechanisms provides valuable insight into both disease progression and potential therapeutic targets.
The program integrates findings from recent research to highlight the complex interplay between brain lipid metabolism, structural and functional changes in neurons, and cognitive outcomes. Emphasis is placed on translational perspectives, connecting molecular and biochemical pathways with clinical manifestations and strategies for early recognition and intervention.
Learning Objectives:
Upon completion of this course, participants will be able to:
- Describe the role of fatty acid metabolism in maintaining neuronal structure, function, and signaling.
- Explain how alterations in lipid metabolism contribute to amyloid-β deposition, tau pathology, and neuroinflammatory processes in Alzheimer disease.
- Correlate metabolic dysfunction with cognitive impairment and disease progression.
- Evaluate current research linking brain fatty acid metabolism to biomarkers and neuropathological changes in Alzheimer disease.
- Identify potential therapeutic and preventive strategies informed by modulation of lipid metabolism.
Course Completion Requirements:
To complete this CE course and receive full credit, participants must:
- Register for the course.
- Review all course materials.
- Complete the post-test with a passing score of 70% or higher.
- Submit a completed course evaluation.
Note: Some courses may include additional assignments or clinical case reviews
Important Disclosures:
- Conflict of Interest: The course planners, authors, and presenters have no financial or commercial conflicts of interest related to this educational activity.
- Commercial Support: This course has not received sponsorship or financial support from commercial entities.
- Non-Endorsement: Approval of this course as a continuing education activity does not imply endorsement of any products, services, or companies mentioned within the content.
- Off-Label Product Use: Any discussion of off-label medication use is clearly identified and supported by available evidence.
Key Course Benefits:
- Enhances understanding of the relationship between fatty acid metabolism and neurodegenerative disease.
- Integrates molecular and clinical perspectives to strengthen translational knowledge.
- Improves ability to connect neuropathological changes with cognitive performance outcomes.
- Supports evidence-based approaches to recognition, prevention, and management of Alzheimer disease.
Approvals and Accreditation:
The CE Learning Network (CELN) is an accredited provider of continuing education for nurses, recognized by the Florida Board of Nursing and the District of Columbia Board of Nursing.
This course adheres to the standards established by the American Nurses Credentialing Center’s Commission on Accreditation.
Approved for the following nursing professionals:
- Florida Board of Nursing: LPNs, RNs, CNSs, ARNPs
- District of Columbia Board of Nursing: RNs, Nurse Anesthetists, CNSs, Midwives, ARNPs
For added convenience, CELN automatically reports earned CE hours to CEBroker.com on behalf of participants.